Skip to Content

Thornburg International Growth C TIGCX

Medalist Rating as of | See Thornburg Investment Hub
  • NAV / 1-Day Return 23.56  /  −0.30 %
  • Total Assets 900.9 Mil
  • Adj. Expense Ratio
    2.280%
  • Expense Ratio 2.280%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 5,000
  • Status Open
  • TTM Yield
  • Turnover 64%

USD | NAV as of May 17, 2024 | 1-Day Return as of May 17, 2024, 10:16 PM GMT+0

Morningstar’s Analysis TIGCX

Will TIGCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Unstable on a few levels.

Senior Analyst Todd Trubey

Todd Trubey

Senior Analyst

Summary

Thornburg International Growth has new managers, a revamped analyst team, and tweaks to its approach. It will take a while for the dust to settle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TIGCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 38.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S ADR

6.09 55.0 Mil
Healthcare

ASML Holding NV

5.69 51.4 Mil
Technology

Taiwan Semiconductor Manufacturing Co Ltd

4.65 42.1 Mil
Technology

Nestle SA

4.37 39.5 Mil
Consumer Defensive

AstraZeneca PLC

3.47 31.3 Mil
Healthcare

Mastercard Inc Class A

3.28 29.6 Mil
Financial Services

Beiersdorf AG

2.81 25.4 Mil
Consumer Defensive

Lonza Group Ltd

2.63 23.7 Mil
Healthcare

Diageo PLC

2.59 23.4 Mil
Consumer Defensive

Icon PLC

2.50 22.6 Mil
Healthcare